92 related articles for article (PubMed ID: 23476966)
1. Targeting cell migration protein could slow cancer cells spreading.
Parks L
Future Med Chem; 2013 Feb; 5(2):122. PubMed ID: 23476966
[No Abstract] [Full Text] [Related]
2. Cell migration/invasion assays and their application in cancer drug discovery.
Eccles SA; Box C; Court W
Biotechnol Annu Rev; 2005; 11():391-421. PubMed ID: 16216785
[TBL] [Abstract][Full Text] [Related]
3. N-cadherin as an invasion promoter: a novel target for antitumor therapy?
Cavallaro U
Curr Opin Investig Drugs; 2004 Dec; 5(12):1274-8. PubMed ID: 15648948
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of cancer cell invasion.
Sahai E
Curr Opin Genet Dev; 2005 Feb; 15(1):87-96. PubMed ID: 15661538
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic targeting of TWEAK/Fnl4 in cancer: exploiting the intrinsic tumor cell killing capacity of the pathway.
Michaelson JS; Burkly LC
Results Probl Cell Differ; 2009; 49():145-60. PubMed ID: 19513634
[TBL] [Abstract][Full Text] [Related]
6. A new role for GABA: inhibition of tumor cell migration.
Ortega A
Trends Pharmacol Sci; 2003 Apr; 24(4):151-4. PubMed ID: 12706998
[TBL] [Abstract][Full Text] [Related]
7. [Cell biology and biochemistry of VX2 cancer cell motility--relevance to its invasiveness and metastatic potential].
Yoshikawa F
Osaka Daigaku Shigaku Zasshi; 1985 Jun; 30(1):87-109. PubMed ID: 3001262
[No Abstract] [Full Text] [Related]
8. Targeting tumors.
Sobel RK
US News World Rep; 2000 Oct; 129(13):48-50. PubMed ID: 11183328
[No Abstract] [Full Text] [Related]
9. Mechanical approaches to oncological drug delivery.
Carlisle R; Coussios CC
Ther Deliv; 2013 Oct; 4(10):1213-5. PubMed ID: 24116903
[No Abstract] [Full Text] [Related]
10. Newly developed strategies for multifunctional mitochondria-targeted agents in cancer therapy.
Zhang E; Zhang C; Su Y; Cheng T; Shi C
Drug Discov Today; 2011 Feb; 16(3-4):140-6. PubMed ID: 21182981
[TBL] [Abstract][Full Text] [Related]
11. Cancer stem cells: getting to the root of cancer.
Azvolinsky A
J Natl Cancer Inst; 2012 Jun; 104(12):893-5. PubMed ID: 22715190
[No Abstract] [Full Text] [Related]
12. Antitumorigenic effects of cannabinoids beyond apoptosis.
Freimuth N; Ramer R; Hinz B
J Pharmacol Exp Ther; 2010 Feb; 332(2):336-44. PubMed ID: 19889794
[TBL] [Abstract][Full Text] [Related]
13. The actin cytoskeleton as a therapeutic target: state of the art and future directions.
Giganti A; Friederich E
Prog Cell Cycle Res; 2003; 5():511-25. PubMed ID: 14593746
[TBL] [Abstract][Full Text] [Related]
14. Slow and fast invasion waves in a model of acid-mediated tumour growth.
Fasano A; Herrero MA; Rodrigo MR
Math Biosci; 2009 Jul; 220(1):45-56. PubMed ID: 19376138
[TBL] [Abstract][Full Text] [Related]
15. Paclitaxel prodrugs: toward smarter delivery of anticancer agents.
Skwarczynski M; Hayashi Y; Kiso Y
J Med Chem; 2006 Dec; 49(25):7253-69. PubMed ID: 17149855
[No Abstract] [Full Text] [Related]
16. The μ-opioid receptor in cancer progression: is there a direct effect?
Lennon FE; Moss J; Singleton PA
Anesthesiology; 2012 Apr; 116(4):940-5. PubMed ID: 22357347
[No Abstract] [Full Text] [Related]
17. [Molecular targeting drugs--present status and future development].
Kuwano M; Fujii T; Ono M; Izumi H; Kohno K
Nihon Rinsho; 2004 Jul; 62(7):1211-5. PubMed ID: 15283135
[TBL] [Abstract][Full Text] [Related]
18. Nanomedicine in cancer treatment.
Yih TC; Wei C
Nanomedicine; 2005 Jun; 1(2):191-2. PubMed ID: 17292078
[No Abstract] [Full Text] [Related]
19. Molecular mechanisms of cancer cell invasion and plasticity.
Wolf K; Friedl P
Br J Dermatol; 2006 May; 154 Suppl 1():11-5. PubMed ID: 16712711
[TBL] [Abstract][Full Text] [Related]
20. Targeting epithelial-to-mesenchymal transition for cancer therapy.
Wang Z
Curr Pharm Des; 2015; 21(10):1239. PubMed ID: 25658676
[No Abstract] [Full Text] [Related]
[Next] [New Search]
